8-K
Current Report
Immunovant, Inc. Filed Acc 0001615774-19-007917
Material agreement · Unregistered share sale
- Item 1.01 Entry into a material definitive agreement
- Item 3.02 Unregistered sales of equity securities
From the SEC's structured data for this filing
Loading s118326_8k.htm…